NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘biotech’

25 May 2016

Albion sells biotech business Haemostatix

blood-75302_1280 Albion Ventures and other investors have sold their stakes in biotech business Haemostatix.

13 April 2016

Month-on-month uptick still leaves biotech PE, VC investment at relative low $

research-1029340_1920 Private equity and venture capital investment in biotech companies received a slight uptick in March, but still recorded one of its leanest results in the past 12 months, new research shows.

10 March 2016

PE, VC biotech investment hits new 12-month low $

flasks-606612_1920 Private equity and venture capital investment in the biotech sector hit a new 12-month low last month amid consecutives falls in both volume and total value.

23 October 2015

Israel Biotech targets $100m for debut fund

isr Newly formed venture capital firm Israel Biotech Fund has launched its first fund with a $100m target, AltAssets understands.

14 October 2015

Year-on-year PE, VC biotech investment jumps despite monthly slide $

tube-786932_1920 The value of private equity, venture capital and development capital investment targeting global biotechnology companies was up more than a third year-on-year in September despite a month-on-month drop.

18 August 2015

Warburg Pincus, Sutter Hill Ventures in $100m consumer-focused genome project

DNA, gene strand Warburg Pincus, the New York-based private equity firm, and Palo Alto, California's Sutter Hill Ventures are joining forces with US gene-sequencing giant Illumina to launch a new company they say will "empower consumers to discover insights into their own genomes".

17 August 2015

UK activity bolsters biotech investment from PE, VC firms $

dna-163466_1280 The value of private equity, venture capital and development capital investment in the global biotechnology sector increased for the second month in a row in July to reach its highest point of 2015 so far new research shows.

20 July 2015

Strong Canadian performance helps boost global PE, VC biotech investment $

flasks-606612_1280 Strong investment in North American biotech companies saw global private equity and venture capital backing within the sector almost double in June compared to the same time last year.

9 July 2015

Wellington Partners major backer in German biotech company’s €29m financing

microscope pixabay Wellington Partners, a venture capital firm with offices in London and Munich, was a cornerstone investor – at €5m – in a €29m financing round at Munich-based biotech company 4SC AG.

8 July 2015

LSP-backed Dutch biotech company Kiadis Pharma raises €33m in IPO

biotech lab clinic research VC-backed Kiadis Pharma has raised €33m after becoming the first Dutch biotech company to list on Euronext Amsterdam in five years.

Page 1 of 1312345...10...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016